Pages that link to "Q39126625"
Jump to navigation
Jump to search
The following pages link to Pharmacokinetic parameters of artesunate and dihydroartemisinin in rats infected with Fasciola hepatica. (Q39126625):
Displaying 10 items.
- Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer (Q34127831) (← links)
- In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78 (Q34290075) (← links)
- Disruption of spermatogenesis in the liver fluke, Fasciola hepatica by two artemisinin derivatives, artemether and artesunate (Q35958217) (← links)
- Pharmacokinetics of the fasciocidal drug candidates MT04 and OZ78 in uninfected rats and in vitro pharmacodynamic studies (Q37390557) (← links)
- Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass Spectrometry (Q37428688) (← links)
- Evaluation of the pharmacokinetic profile of artesunate, artemether and their metabolites in sheep naturally infected with Fasciola hepatica (Q38980416) (← links)
- Development and validation of a liquid chromatography and ion spray tandem mass spectrometry method for the quantification of artesunate, artemether and their major metabolites dihydroartemisinin and dihydroartemisinin-glucuronide in sheep plasma. (Q38980419) (← links)
- Determination of artemether and dihydroartemisinin in human plasma with a new hydrogen peroxide stabilization method (Q41847661) (← links)
- Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer. (Q44872854) (← links)
- Exogenous Iron Increases Fasciocidal Activity and Hepatocellular Toxicity of the Synthetic Endoperoxides OZ78 and MT04 (Q90460013) (← links)